Page not found

You are here

Tanner Caverly has been a general internist and Health Services Research Fellow at the Ann Arbor VA Medical Center and a Clinical Lecturer at the University of Michigan Medical School since July 2013. He graduated from medical school at The Ohio State University School of Medicine and Public Health, and subsequently traveled to the University of Colorado, where he completed internal medicine residency training, a year as Chief Medical Resident, and a Primary Care Research Fellowship / Masters in Public Health.

Jeff Kullgren was recently quoted in the article, "Uninsured struggle to obtain, afford doctor appointments." Dr. Kullgren commented, ""Even though the ACA has led to improvements, there is still a substantial (number) of individuals who don't have health insurance...And even for people who are insured, deductibles have climbed dramatically in recent years."

PANELISTS :
- Paula Johnson, President of Wellesley College, Chairperson of the National Academies committee, and member, American Academy of Arts and Sciences and the National Academy of Medicine
- Reshma Jagsi, Professor and Deputy Chair in the Department of Radiation Oncology at Michigan Medicine and Director of the Center for Bioethics and Social Sciences in Medicine, U-M

REPORT SUMMARY & MODERATION:
- Lilia Cortina,* Associate Director of ADVANCE for the College of LSA; Professor of Psychology, Women’s Studies, and Management and Organizations, U-M
- Anna Kirkland,* Director of the Institute for Research on Women and Gender; Arthur F. Thurnau Professor of Women’s Studies, U-M

In 2016, the National Academies of Sciences, Engineering, and Medicine assembled a committee to conduct a study on the impact of sexual harassment in academia on the career advancement of women in the scientific, technical, and medical workforce. The committee published a comprehensive report titled, "Sexual Harassment of Women: Climate, Culture, and Consequences in Academic Sciences, Engineering, and Medicine," in June 2018. The report identifies key findings on the causes and impacts of sexual harassment, and recommendations for institutional policies, strategies, and practices to address and prevent it.

Preventing and effectively addressing sexual harassment of women in colleges and universities has remained a challenge for decades. More than half of women faculty and staff report having been harassed. Student surveys of university systems show disturbingly similar rates, with 20–50% of women students experiencing sexually harassing behavior perpetrated by faculty or staff.

Persistent sexual harassment in STEM fields, and its adverse impacts on women’s careers, jeopardizes progress in closing the gender gap, damages research integrity, and results in a costly loss of talent. Academic sciences, engineering, and medicine share characteristics that create conditions for harassment, but many findings of the report are not limited to STEM field settings. Other fields within academia can be similarly male-dominated, hierarchical work and learning settings in which abusive cultures may form. Such environments can silence and limit the career opportunities for both the targets of the sexual harassment and bystanders, causing both men and women to leave their fields.

This panel will include a summary of the report, discussion from the report’s co-authors, commentary from disciplinary experts, and Q&A with the audience.

The panel will offer broad discussion of use to any member of the university community or the public interested in sexual harassment in academia. A reception will follow.

Sexual Harassment in the Academy Panel Discussion Series is presented by IRWG and the Office of Research, with co-sponsorship from: ADVANCE, The Office for Health Equity and Inclusion, the College of Literature Sciences, and the Arts, and the College of Engineering

Dr. Stephanie Kukora is a clinical lecturer in Neonatal-Perinatal Medicine at the University of Michigan Mott Children’s Hospital in Ann Arbor. She completed pediatric bioethics training through the Kansas City Children’s Hospital, under the instruction of Drs.

Dean Shumway was an Assistant Professor of Radiation Oncology with the University of Michigan Health System and the Ann Arbor VA Medical Center. He received his M.D. from the University of Chicago and completed his residency training at the University of Michigan, where he served as Chief Resident. His research focuses on advancing the quality of care received by breast cancer patients, with emphasis on improving individualized care by developing interventions to enhance decision making.

Dr. Sussman is a Research Scientist in the Center for Clinical Management Research at the Veterans Affairs Ann Arbor Health System and an Assistant Professor in the Department of Internal Medicine at the University of Michigan Medical School. He attended medical school at the University of California, San Francisco, completed internal medicine residency at Yale-New Haven Hospital, and was a Robert Wood Johnson Foundation Clinical Scholar at the University of Michigan.

Beth A. Tarini is an Associate Professor of Pediatrics & Division Director of General Pediatrics and Adolescent Medicine at the University of Iowa. Before that, she was an Assistant Professor in the UM Department of Pediatrics and Communicable Diseases. She received her MD from Albert Einstein College of Medicine (2001) and a master's degree from the University of Washington (2006), where she was a Robert Wood Johnson Clinical Scholar. In addition to her clinical interest in preventative care, she pursues an active research program on issues of newborn screening and genetic testing.

Jeffrey Kullgren was recently interviewed for the US News & World Report article, "Why You Should Talk to Your Doctor About Drug Pricing." According to Dr. Kullgren, "It's important then, especially if a patient's health changes as they age, to periodically be reviewing those medications with their health care team to ensure that they are able to get the medications that are going to be the most beneficial to them, while we avoid prescribing medications to patients who are unlikely to benefit from them and for who those unneeded prescriptions can lead to cost burdens."

It's become a holiday tradition, but the cookie dough controversy is back in the news! New highlights include Brian Zikmund-Fisher's Dr. Seuss-inspired Twitter responses to the FDA's Scott Gottlieb's (also Dr. Seussian) warnings against consumption of raw cookie dough.

Due to food safety concerns, the FDA recently released a statement that strongly advises the public from indulging in raw cookie dough. In Brian Zikmund-Fisher response to the FDA's warning in The Conversation, he discusses balancing the minimization of risk with the maximization of life: "...let’s all please remind ourselves that our goal is not to minimize all risk, no matter the cost. Our goal is to maximize life. Sometimes maximizing life means warning people that their flour is contaminated and making sure they throw it out. Sometimes maximizing life means letting them enjoy some (carefully prepared) cookie dough without shame."